ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Canon Medical Highlights Vertical Integration of MRI Portfolio at RSNA 2025

Tustin, Ca, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Canon Medical Systems USA, Inc., highlights its vertical integration of its magnetic resonance imaging (MRI) portfolio which encompasses the in-house design and manufacturing of key system components, including magnets, and radiofrequency (RF) coils, along with an integrated AI-powered workflow. Canon Medical will showcase how this integration is designed to support system harmony and workflow efficiency at the Radiological Society of North America (RSNA) 2025 annual meeting (Booth #7313).

 

By overseeing the design and production of magnets for both 1.5T and 3T systems, as well as RF coils, Canon has created a comprehensive hardware platform. This platform is connected to Canon's proprietary post-processing solutions, Vitrea and Olea, to create a streamlined pipeline from image acquisition to diagnostic review.

 

"Our control over the engineering and manufacturing process allows us to design and optimize the MRI system to achieve a consistent performance profile," said Mark Totina, Director, MR Business Unit, at Canon Medical Systems USA. "We believe that when our magnets, gradients, and coils are matched with our AI software, it can help reduce integration challenges and is designed to deliver a greater level of performance."

 

A Comprehensive AI-Integrated Workflow

Canon's portfolio includes an AI-integrated workflow that begins before the patient enters the magnet. The ecosystem includes:

  • Ceiling Camera: Aims to assist with automated patient positioning.
  • Auto Scan Assist & AI Slice Alignment: Designed for simplified, consistent exam setup.
  • Iterative Motion Correction (IMC): AI-powered motion correction to help mitigate scan repeats.
  • Advanced integrated IQ Engine (AiCE) and Precise IQ Engine (PIQE): Deep Learning-based reconstruction and post-processing for image quality.

 

To date, Canon's AI-powered post-processing features have been utilized in over 550,000 cases. *

 

Clinical Experience and Platform Enhancements

The clinical application of Canon's approach is demonstrated by sites such as Steinberg Diagnostic Medical Imaging (SDMI). At SDMI, the Canon Galan Supreme Edition 3T MR system has supported a high-volume workflow, imaging nearly 3,000 patients since its implementation in May 2025, averaging 20 studies per day. This efficiency helps support a streamlined patient experience, augmented by integrated AI features, including AiCE and PIQE, which are designed to deliver consistent, high-quality imaging.

Following this launch, Canon is expanding its Version 10 software upgrade to its newest 1.5T platforms, including the Vantage Orian and Vantage Fortian systems. This upgrade makes advanced features from 3T systems available on the 1.5T fleet.

 

Visit Canon at RSNA 2025

Experience Canon's MRI portfolio at RSNA 2025 in Chicago, November 30 – December 4, at the Canon Medical Booth #7313. Watch demonstrations of the AI workflow and discover the company's approach to vertical integration.

 

*Based on internal data. AI has been employed across the Fortian, Orian, and Galan systems.


Olivia Duarte
Canon Medical Systems USA
(800) 421-1968
oduarte@us.medical.canon

Recent Quotes

View More
Symbol Price Change (%)
AMZN  220.69
+3.55 (1.63%)
AAPL  271.49
+5.24 (1.97%)
AMD  203.78
-2.24 (-1.09%)
BAC  51.56
+0.56 (1.10%)
GOOG  299.65
+9.67 (3.33%)
META  594.25
+5.10 (0.87%)
MSFT  472.12
-6.31 (-1.32%)
NVDA  178.88
-1.76 (-0.97%)
ORCL  198.76
-11.93 (-5.66%)
TSLA  391.09
-4.14 (-1.05%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.